Determinants of disease and disability in the elderly: The Rotterdam elderly study
Tóm tắt
Từ khóa
Tài liệu tham khảo
1.AclimandosW.A., GallowayN.R. Blindness in the City of Nottingham (1980?1985). Eye 1988; 2: 431?434.
Allaart C.F., Aronson D.C., Ruys Th, et al. Hereditary Protein S deficiency in young adults with arterial occlusive disease. Thromb Haemost 1991 (in press).
3.AmaducciL.A., FratiglioniL., RoccaW.A., et al. Risk factors for clinically diagnosed Alzheimer's disease: a case-control study of an Italian population. Neurology 1986; 36: 922?31.
Aspirin Myocardial Infarction Study Research Group. A randomized controlled trial of aspirin in persons recovered from myocardial infarction. JAMA 1980; 243: 661?9.
5.BerkumF.N.R.van, BirkenhdgerJ.C., vanVeenL.C.P., et al. Noninvasive axial and peripheral assessment of bone mineral content: A comparison between osteoporotic women and normal subjects. J Bone Min Res 1989; 4: 679?85.
Bijl R.V., Nederlands Centrum voor de Geestelijke Volksgezondheidszorg, Scenariorapport. Onderzoek Geestelijke Gezondheidszorg. STG publication, in press.
7.BinswangerO. Die Begrenzung der allgememen progessiven Paralysie. Berl Klin Wochenschr 1894; 31: 1103?5, 1137?9, 1180?6.
Breslau P.J. Ultrasonic Duplex scanning in the evaluation of carotid artery disease. Maastricht: Thesis, 1982.
10.BriëtE., EngesserL., BrommerE.J.P., Broekmans A.W., BertinaR.M. Thrombophilia: its causes and a rough estimate of its prevalence. Thromb Haemost 1987; 58: 39?43
11.CannerP.L. Aspirin in coronary heart disease. Comparison of six clinical trials. Isr J Med Sci 1983; 19: 413?23.
Chandra V., Kohmen E., Schoenberg B.S. Head trauma with loss of conciousness as a risk factor for Alzheimer's disease using prospectively collected data. Neurology; 37: 152.
Claessens A.A.M.C., Schouten J.S.A.G., Vandenouweland F.A., Valkenburg H.A. Do clinical findings associate with radiographic osteoarthritis of the knee? Ann Rheum Dis 1991 (in press).
14.CobbS. The frequency of rheumatic diseases. Harvard Un Press 1971, Cambridge.
Consensus Committee. Consensus development conference: prophylaxis and treatment of osteoporosis. Br Med J 1987; 295: 914?1915
17.CoonW.W. Epidemiology of venous thromboembolism. Ann Surgery 1977; 186: 194?9.
18.CopelandJ.R.M., KellekerM.J., KellettJ.M., et al. A semi-structured clinical interview for the assessment of diagnosis and mental state in the elderly: the Geriatric Mental State Schedule. Psychol Med 1976;6:439?49.
20.CummingsS.R., KelseyJ.L., NevittM.C., O'Dowd K.J. Epidemiology of osteoporosis and osteoporotic fractures. Epidemiol Rev 1985; 7: 178?209.
21.DaviesM.J., ThomasA. Thrombosis and acute coronary-artery lesions in sudden cardiac ischemic death. N Engl J Med 1984; 310: 1137?40.
Dewey M.E., Copeland J.R.M., Hofman A., eds. Case finding for dementia in epidemiological studies. Eurodem Report 1, Liverpool, 1990.
23.DuthieE.H., GlattS.L.. Understanding and treating multi-infarct dementia. Clin Geriatr Med 1988; 9: 749?66.
24.FerrisF.L. Senile macular degeneration: review of epidemiologic features. Am J Epidemiol 1983; 118: 132?151.
25.FitzgeraldD.J., RoyL., CatellaF., Fitz Gerald G.A. Platelet activation in unstable coronary disease. N Engl J Med 1986; 315: 983?9.
26.FowkesF.G.R. The measurement of atherosclerotic peripheral arterial disease in epidemilogical surveys. Int J Epidemiol 1988; 17: 248?54.
27.FriedL.P., BushT.L. Morbidity as a focus of preventive health care in the elderly. Epidemiol Rev 1988; 10: 48?64
29.FriesJ.F., GreenL.W., LevineS. Health Promotion and the compresion of morbidity. Lancet 1989; i: 481?3.
30.FusterV., Walter BowieE.J., LewisJ.C., Fass D.N., OwenC.A. Jr., BrownA.L. Resistance to arteriosclerosis in pigs with von Willebrand's disease. J Clin Invest 1978; 61: 722?730.
31.GhafourI.M., AllanD., FouldsW.S. Common causes of blindness and visual handicap in the west of Scotland. Br J Ophthalmol 1983; 67: 209?213.
32.GibsonJ.M., LaveryJ.R., RosenthalA.R.Blindness and partial sight in an elderly population. Br J Ophthalmol 1986; 70: 700?705.
33.GrobbeeDE. Hart en vaatziekten. In: Van der Maas PJ, Hofman A, Dekker E, ed. De epidemiologische basis van gezondheidsbeleid. Samson Stafleu: Alphen aan de Rijn, 1988.
34.Gunning-SchepersL.J., BarendregtJ.J., Van derMaasP.J. Population interventions reassessed. Lancet 1989; i: 479?81.
35.HachinskyV.C., LasserN.A., MarshallJ. Multiinfarct dementia: a cause of mental deterioration in the elderly. Lancet 1974; ii: 207?9?11.
36.HamstenA., WalldiusG., SzamosiA. et al. Plasminogen Activator Inhibitor in Plasma: Risk Factor for recurrent Myocardial Infarction. Lancet 1987; ii: 3?8.
Haynes S.G., Feinleib M., eds. The epidemiology of ageing. NIH publication 80-969, 1980.
41.HeymanA., WilkonsonW.E., StaffordJ.A., et al. Alzheimer's disease: a study of epidemiological aspects. Ann Neurol 1984; 15: 335?41.
42.HofmanA., SchutteW., TanjaT.A. et al. History of dementia and Parkinson's disease in 1st-degree relatives of patients with Alzheimer's disease. Neurology 1989, 39: 1589?92.
Hofman A., Rocca W.A., Brayne C., et al. The prevalence of dementia in Europe. Int J Epidemiol 1991 (in press).
44.HoogendoornD. Enkele gegevens over 64.453 fracturen van het proximale uiteinde van het femur (collum plus trochantergebied) 1967?1979. Ned Tijdschr Geneeskd 1982; 126: 963?968
45.HuiS.L., WiskeP.S., NortonJ.A., JohnstonC.C. A prospective study of change in bone mass with age in post menopausal women. J Chron Dis 1982; 35: 715?725
46.HuseD.M., OsterG., KillenA.R., LaceyM.J., ColditzG.A. The economic costs of non-insulindependent diabetes mellitus. JAMA 1989; 262: 2708?13.
48.IsoM., FolsomA.R., WuK.K., et al. Hemostatic variables in Japanese and Caucasian men. Am J Epidemiol 1989; 130: 925?34.
Jonker C., Hooijer C. Seniele dementie type Alzheimer. Dissertation VU Amsterdam, 1986.
50.Juhan-VagueL, AlessiM.C., JolyP. et al. Plasma Plasminogen Activator Inhibitor-1 in Angina Pectoris. Influence of Plasma Insulin and acute-phase response. Arteriosclerosis 1989; 9: 362?66.
51.KannelW.B., WolfP.A., CastelliW.P., D'Agostino R.B. Fibrinogen and risk of cardiovascular disease: The Framingham study. JAMA 1987; 258: 1183?6.
52.KannelW.B., WolfP.A., McGeeD.L., Dawber T.R., McNamaraP., CastelliW.P. Systolic blood pressure, arterial rigidity and risk of stroke: The Framingham study. JAMA 1981; 245: 1225?9.
53.KrolewskiA.S. Epidemiology of diabetes mellitus. In: Joslin's Diabetes Mellitus. Philadelphia: Lea & Febiger, 1985.
54.LechnerH., SchmidtR., BerthaG., JustichE., OffenbacherH., SchneiderG. Nuclear magnetic resonance image white matter lesions and risk factors for stroke in normal individuals. Stroke 1988; 19: 263?5.
55.LeibowitzH.M., KruegerD.E., MaunderL.R., et al. The Framingham Eye Study Monograph. An ophthalmological and epidemiological study of cataract, glaucoma, diabetic retinopathy, macular degeneration, and visual acuity in a general population of 2631 adults, 1973?1975. Survey Ophthalmol 1980; 24: 335?610.
57.LevyD., GarrisonR.J., SavageD.D., KannelW.B., CastelliW.P. Left ventricular mass and incidence of coronary heart disease in an elderly cohort. Ann Int Med 1989; 110: 101?7.
58.LevyD., AndersonK., SavageD.D., KannelW.B., ChristiansenJ.C., CastelliW.P. Echocardiographically detected left ventricular hypertrophy: Prevalence and risk factors. Ann Int Med 1988; 108: 7?13.
59.LoeligerE.A. Oral anticoagulation in the secondary prevention of myocardial infarction. Acta Med Scand 1981; 210 (S651): 305?15.
61.McCormickJ. and SkrabauchP. Coronary heart disease is not preventable by population interventions. Lancet 1988; ii: 839?41.
62.McKhannG., DrachmanD., FolsteinM., et al. Clinical diagnosis of Alzheimer's disease. Neurology 1984; 34: 939?44.
63.MeadeT.W., NorthW.R.S. Population based distributions of haemostatic variables. Br Med Bull 1977; 33: 283?8.
64.MeadeT.W., NorthW.R.S., ChakrabartiR, et al. Haemostatic function and cardiovascular death: Early results of a prospective study. Lancet 1980; i: 1050?4.
65.MeadeT.W., MellowsS., BroznovicM., et al. Haemostatic function and ischaemic heart disease: Principal results of the Northwhick Park Heart Study. Lancet 1986; ii: 533?7.
66.MeierD.E., OrwollE.S., JonesJ.M. Marked disparity between trabecular and cortical bone loss with age in healthy men. Ann Int Med 1984; 101: 605?612.
67.MeltonJ.L., WahnerH.W., RichelsonL.S., O'FallonW.M., RiggsB.L. Osteoporosis and the risk of hip fracture. Am J Epidemiol 1986; 124: 254?261.
Merode van T. The use of a multi-gate pulsed Doppler system in the evaluation of the carotid artery circulation. Maastricht: Thesis, 1986.
69.MortimerJ., FrenchL.R., HuttonJ.T., et al. Head injury as a risk factor for Alzheimer's disease. Neurology 1985; 35: 264?7.
70.NevittM.P., BallardD.J., HallettJ.W. Prognosis of abdominal aortic aneurysms: A population based study. N Engl J Med 1989; 321: 1009?14.
71.Newton-JohnH.F., MorganD.B. The loss of bone with age, osteoporosis and fractures. Clin Orthop Rel Res 1970; 72: 229?252
72.NicholsT.C., BellingerD.A., JohnsonT.A., Lamb M.A., GriggsT.R. Von Willebrand's disease prevents occlusive thrombosis in stenosed and injured porcine coronary arteries. Circulation Res 1986; 59: 15?26.
Norris J.M., Dorman J.S., LaPorte R.E., et al. Clustering of premature mortality in 1,761 insulin-dependent diabetics and their family members.
74.OliverM.F. Prevention of coronary heart disease. Propaganda, promises, problems and prospects. Circulation 1986; 73: 1?9.
75.OsbornG.R. The incubation period of coronary thrombosis. London: Butterworths, 1963.
Persantin-Aspirin Reinfarction Study Research Group. Part 11. Secondary prevention with persantin and aspirin. J Am Coll Cardiol 1986; 7: 251?69.
77.PetoR., GrayR., CollinsR., WheatlyK., HennekensC., JarnzorikK., WarlowC., Hafner B., ThompsonE., NortonS., GillilandS., DollR. Randomised trial of prophylactic daily aspirin in British male doctors. Br Med J 1988; 296: 313?6.
78.PleumeekersH., van derDoesE., GrobbeeD.E. Screening for abdominal aortic aneurysms. (Re) Ned Tijdschr Geneeskd 1989; 133: 1522.
Prevention of cardiovascular disease among the elderly. Report of a WHO meeting. World Health Organization: Geneva, 1987.
81.ReavenG.M. Role of insulin resistance in human disease. Banting lecture. Diabetes 1988; 37: 1595?607.
82.RiggsB.L., MeltonL.J. Evidence for two distinct syndromes of involutional osteoporosis. Am J Med 1983; 75: 899?901.
84.RiisB.J., ChristiansenC. Measurement of spinal or peripheral bone mass to estimate early postmenopausal bone loss? Am J Med 1988; 84: 646?653.
85.RobertsonD.A., HaleP.J., NattrassM. Macrovascular disease and hyperinsulinaemia. Bull Clin Endocrin Metab 1988; 2: 407?24.
86.RoccaW.A., AmaducciL.A., SchoenbergB.S. Epidemiology of clinically diagnosed Alzheimer's disease. Ann Neurol 1986; 19: 415?24.
89.SaasseJ.L.C.M.van, VanRomundeL.K.J., Cats A., VandenbrouckeJ.P., ValkenburgH.A. Epidemiology of osteoarthritis: Zoetermeer Survey. Ann Rheum Dis 1989; 48: 271?80.
90.SalonenR., SolonenJ.T. Progression of carotid atherosclerosis and its determinants: A population-based ultrasonography study. Atherosclerosis 1990; 81: 33?40.
91.SchoenbergB.S., KokmenE., OhazakiH. Alzheimer's disease and other dementing illnesses in a defined United States population: incidence rates and clinical features. Ann Neurol 1987; 22: 724?9.
Sixty Plus Reinfarction Study research group. A double-blind trial to assess longterm oral anticoagulant therapy in elderly patients after myocardial infarction. Lancet 1980: 989?993.
93.SlemendaC.W., JohnstonC.C. Bone Mass measurement: which site to measure. Am J Med 1988; 84: 643?645.
94.StahelinH.B. Senile dementia in relation to nutritional factors. Bibl Nutr Dieta 1986; 38: 136?44.
95.StolkR.P., GrobbeeD.E. Insulin and ischemic cardiovascular disease. J Drug Res 1990; 15: 165?9.
96.StoutR.W., CrawfordV. Active life expectancy and terminal dependency: Trends in long-term geriatric care over 33 years. Lancet 1988; i: 281?3.
97.StrasserT., ed. Cardiovascular care of the elderly. Geneva: World Health Organization, 1985.
98.SulkavaR., ErliunjunttiT., PaloJ. Head injury in Alzheimer's disease and vascular dementia. Neurology 1985;35:1530?1.
The Steering Committee of the Physicians Health Study Research Group. Final report on the aspirin component of the ongoing Physicians' Health Study. N Engl J Med 1989; 321: 129?35.
The ARIL Investigators. The Atherosclerosis Risk in Communities (ARIL) Study: Design and Objectives. Am J Epidemiology 1989; 129: 687?702.
101.ThompsonS.G., DuckertF., HaverkateF. et al. The Measurement of Haemostasis factors in 16 European Laboratories: Quality Thrombosis and Haemostasis 1989; 61: 301?306.
102.TrouerbachW.Th., HoornstraK., Birkenhäger J.C., ZwambornA.W. Röntgendensitometric study of the phalanx. Diagn Im Clin Med 1985; 54: 64?77.
103.VroonhovenT.van. Screening for abdominal aortic anuerysms. Ned Tijdschr Geneeskd 1989; 133: 1061?2.
104.WattsE. Reduced fibrinolytic activity as cardiovascular disease risk-factor. Lancet 1986; ii: 809.
105.WelinL., SvärsudK., WilhelmsenL., LarssonB., TibblinG. Analysis of risk- factors for stroke in a cohort of men born in 1913. N Engl J Med 1987; 317: 521?6.
WHO.International Classification of Impairments, Disabilities and Handicaps. WHO, 1980, Geneva.
107.WilhelmsenL., SvarsuddK., Korsan-BengstenK., et al. Fibrinogen as a risk- factor for stroke and myocardial infarction. N Engl J Med 1984; 311: 501?5.
108.WilsonD.B., GuyattG.H, StreinerD.L. The diagnosis of dementia. CMAJ 1987; 137: 625?9.